2020-03-30
Alnylam Pharmaceuticals Inc., a biopharmaceutical company focusing on the research, development, and commercialization of RNA interference therapeutics for genetically defined diseases, in collaboration with Vir Biotechnology Inc., a clinical-stage immunology company specializing in the treatment and prevention of serious infectious diseases, are working to develop and commercialize an...
